Virtus Fund Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	$39.2K	Buy	+2,135	New	+$39.2K	0.12%	81
2017 Q4	$993K	Buy	+32,970	New	+$993K	0.01%	287
2014 Q3	–	Sell	-6,723	Closed	-$152K	–	1159
2014 Q2	$152K	Buy	+6,723	New	+$152K	﹤0.01%	1108